StockWaves
  • Home
  • Global Markets
    Global MarketsShow More
    2 progress shares backed by this British fund that’s soared 77.8% in simply 3 years!
    2 progress shares backed by this British fund that’s soared 77.8% in simply 3 years!
    4 Min Read
    Inventory market at present: Reside updates
    Inventory market at present: Reside updates
    3 Min Read
    Iran to carry nuclear talks with European powers on Friday
    Iran to carry nuclear talks with European powers on Friday
    0 Min Read
    See how a lot a 50-year-old ought to make investments to get a £1k month-to-month passive revenue at 65
    See how a lot a 50-year-old ought to make investments to get a £1k month-to-month passive revenue at 65
    5 Min Read
    Trump disputes WSJ report on Bessent speaking him out of firing Powell
    Trump disputes WSJ report on Bessent speaking him out of firing Powell
    3 Min Read
  • Investment Strategies
    Investment StrategiesShow More
    Prime information and market movers this week: 18th Jul’ 2025
    Prime information and market movers this week: 18th Jul’ 2025
    2 Min Read
    Fund Radar: Do pharma funds provide immunity in a sick market?
    Fund Radar: Do pharma funds provide immunity in a sick market?
    0 Min Read
    Navigating stormy markets with self-discipline
    Navigating stormy markets with self-discipline
    0 Min Read
    'I don't consider pure buy-and-hold works'
    'I don't consider pure buy-and-hold works'
    0 Min Read
    Inside Funds: What mutual funds are doing now
    Inside Funds: What mutual funds are doing now
    0 Min Read
  • Market Analysis
    Market AnalysisShow More
    Wall Avenue week forward: Buyers eye Q2 earnings from Tesla, Google, Intel, Basic Motors, and Jerome Powell’s speech
    Wall Avenue week forward: Buyers eye Q2 earnings from Tesla, Google, Intel, Basic Motors, and Jerome Powell’s speech
    3 Min Read
    Russian oil main condemns EU sanctions on Indian refinery, calls it a risk to the nation’s financial system
    Russian oil main condemns EU sanctions on Indian refinery, calls it a risk to the nation’s financial system
    5 Min Read
    The Weekly Wrap | Leverage, Buffett Fashion
    The Weekly Wrap | Leverage, Buffett Fashion
    23 Min Read
    Sona Comstar inventory to be in deal with Monday after autoparts maker indicators to arrange JV in China — Particulars right here
    Sona Comstar inventory to be in deal with Monday after autoparts maker indicators to arrange JV in China — Particulars right here
    4 Min Read
    Fund Radar: Chase winners, wager on laggards or keep chill?
    Fund Radar: Chase winners, wager on laggards or keep chill?
    0 Min Read
  • Trading
    TradingShow More
    Overlook ‘Wealth’: Warren Buffett Says This Phrase Is the True Measure of Success
    Overlook ‘Wealth’: Warren Buffett Says This Phrase Is the True Measure of Success
    3 Min Read
    Buying and selling Room RECAP 7.18.25 | Polaris Buying and selling Group for Shares and Futures Merchants
    Buying and selling Room RECAP 7.18.25 | Polaris Buying and selling Group for Shares and Futures Merchants
    2 Min Read
    Kevin O’Leary Advocates Entrepreneurship Over Consulting to College students: ‘Why Would Anyone Burn All These Hours Whereas Somebody Else Makes Cash?’
    Kevin O’Leary Advocates Entrepreneurship Over Consulting to College students: ‘Why Would Anyone Burn All These Hours Whereas Somebody Else Makes Cash?’
    3 Min Read
    Elizabeth Warren Sounds Alarm on Tariffs: ‘The Affect of Six Months of Donald Trump Will Be Felt for Two Generations’
    Elizabeth Warren Sounds Alarm on Tariffs: ‘The Affect of Six Months of Donald Trump Will Be Felt for Two Generations’
    3 Min Read
    Jensen Huang Says America ‘Misplaced’ The 5G Race By Expertise, Coverage And Dangerous Strategic Considering: ‘Can’t Permit That To Occur’ With AI And 6G
    Jensen Huang Says America ‘Misplaced’ The 5G Race By Expertise, Coverage And Dangerous Strategic Considering: ‘Can’t Permit That To Occur’ With AI And 6G
    3 Min Read
Reading: An Interview with Dr. Divneet Kaur, CEO of Dermabay
Share
Font ResizerAa
StockWavesStockWaves
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Search
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Follow US
2024 © StockWaves.in. All Rights Reserved.
StockWaves > Business > An Interview with Dr. Divneet Kaur, CEO of Dermabay
Business

An Interview with Dr. Divneet Kaur, CEO of Dermabay

StockWaves By StockWaves Last updated: July 16, 2025 7 Min Read
An Interview with Dr. Divneet Kaur, CEO of Dermabay
SHARE


Contents
An Interview with Dr. Divneet Kaur, a Pharmaceutical Scientist, Co-Founder & CEO of Dermabay, a science-first, formulation-led Indian skincare modelAre you able to share your journey into the pharmaceutical business and what impressed you to co-found Dermabay?What distinctive challenges did you face whereas establishing Dermabay, and the way did you overcome them?Are you able to focus on the analysis and improvement course of behind Dermabay’s merchandise?How does Dermabay differentiate itself from different firms within the pharmaceutical and skincare sectors?How do you guarantee the protection and efficacy of your merchandise throughout the improvement course of?How do you method collaboration with different scientists and researchers within the area?What recommendation would you give to aspiring entrepreneurs within the pharmaceutical business?

An Interview with Dr. Divneet Kaur, a Pharmaceutical Scientist, Co-Founder & CEO of Dermabay, a science-first, formulation-led Indian skincare model

In an unique interview, we converse with Dr. Divneet Kaur, Co-Founder & CEO of Dermabay, a science-first, formulation-led Indian skincare model. Discover her journey and imaginative and prescient for revolutionary magnificence.

Are you able to share your journey into the pharmaceutical business and what impressed you to co-found Dermabay?

Dr. Divneet Kaur: I entered pharmaceutical sciences to specialise in drug supply programs and transdermal peptide applied sciences. The most important subject I noticed throughout my time working throughout analysis labs and mentoring college students was the growing disconnect between scientific breakthroughs and client accessibility of skincare merchandise.

I skilled many requests from folks in my setting about their skincare merchandise failing to ship regardless of their costly pricing and worldwide origins. That was my turning level.

The scientific group in India possessed all mandatory data however did not translate analysis into sensible skincare options. This discovery remodeled into the inspiration that created Dermabay.

What distinctive challenges did you face whereas establishing Dermabay, and the way did you overcome them?

Dr. Divneet Kaur: The most important impediment we confronted was staying away from widespread practices of latest skincare manufacturers which concerned white-labeling or blindly following the traits.

Our firm made an intentional resolution to supply each components internally by conducting thorough testing and taking full accountability for our provide chain administration.

We pursued this method to make sure formulation integrity on the expense of prolonged manufacturing timelines and elevated prices.

The primary problem concerned educating customers in regards to the significance of ingredient transparency and stability alongside bioavailability. We achieved this by telling tales primarily based on scientific details as a substitute of utilizing promotional gimmicks.

Are you able to focus on the analysis and improvement course of behind Dermabay’s merchandise?

Dr. Divneet Kaur: Each product begins with figuring out its scientific goal which incorporates understanding the problem-solution and the actives that present effectiveness below Indian situations.

Our R&D group comprising of pharmaceutical marvels and dermatology consultants begins by growing prototypes which mix steady molecules with optimized absorption patterns and organic compatibility.

Our group then conducts successive rounds of inner product testing which results in modifications primarily based on prompt suggestions. The lengthy deliberate improvement course of allows us to construct skincare merchandise that ship efficiency slightly than traits.

How does Dermabay differentiate itself from different firms within the pharmaceutical and skincare sectors?

Dr. Divneet Kaur: Dermabay connects pharmaceutical-grade formulation to skin-first empathy. Our firm focuses on utilizing imported energetic elements along with advertising tales for skincare merchandise as a result of we think about medical perform alongside indigenous formulation design and long-term pores and skin compatibility.

We don’t promote routines—they’re remodeled into tangible outcomes. Our dedication to scientific excellence and sincere communication about pores and skin well being has remained fixed from our humble beginnings to working with main dermatologists in India.

Our genuine model identification mixed with our full management over formulation mental property makes us distinctive out there.

How do you guarantee the protection and efficacy of your merchandise throughout the improvement course of?

Dr. Divneet Kaur: Our formulations obtain the identical degree of consideration as drug molecules throughout the improvement course of. We prioritize security and efficacy collectively by following these important ideas:

  • Ingredient sourcing from verified suppliers
  • Energetic focus primarily based on medical data
  • Stability testing in assorted Indian temperatures and humidity ranges
  • Patch testing for sensitivity and irritation
  • Compliance with regulatory and dermatological requirements

We check new merchandise on precise customers in managed settings earlier than releasing them into market. All merchandise have to show their efficiency on actual Indian pores and skin by means of knowledge proof and safe confidence earlier than they are often launched to the general public.

How do you method collaboration with different scientists and researchers within the area?

Dr. Divneet Kaur: We contemplate collaboration to be an important obligation as a substitute of an elective selection. Our firm conducts common consultations with dermatologists together with beauty chemists and pharmacologists to enhance our formulation strategies.

Our product prototypes obtain steady suggestions from exterior researchers all through the event course of.

I preserve common contact with educational establishments whereas mentoring younger researchers as a result of I consider scientists ought to work collectively as a substitute of competing towards one another.

What recommendation would you give to aspiring entrepreneurs within the pharmaceutical business?

Dr. Divneet Kaur: Construct for depth, not velocity. Pharmaceutical science requires scientists to show persistence and precision and to keep up a humble method to their work.

Actual-world impact takes priority over fast market entry. Your group ought to embody consultants who each perceive scientific ideas and client wants.

The method of innovation turns into profitable by means of your capability to simplify advanced concepts into easy-to-understand ideas and develop options that deal with real-world issues.

Your credibility capabilities as your monetary useful resource so you could defend it towards any potential threats.

Dr. Kaur’s insights illuminate Dermabay’s dedication to efficient, evidence-based skincare. Her imaginative and prescient empowers customers with scientifically crafted merchandise, shaping the way forward for Indian magnificence.



Are you an
Entrepreneur or Startup?


Do you’ve a Success Story to Share?

SugerMint wish to share your success story.
We cowl entrepreneur Tales, Startup Information, Ladies entrepreneur tales, and Startup tales


Discover Success story of Indian entrepreneurs & startups at SugerMint. Comply with us on Twitter, Instagram, Fb, LinkedIn



Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Previous Article Asian shares decline: Asian shares decline as Fed price lower bets wane Asian shares decline: Asian shares decline as Fed price lower bets wane
Next Article Mike Johnson Breaks Ranks With Trump On The ‘Very Delicate Topic’ Of Epstein: ‘I am For Transparency’ – Tesla (NASDAQ:TSLA) Mike Johnson Breaks Ranks With Trump On The ‘Very Delicate Topic’ Of Epstein: ‘I am For Transparency’ – Tesla (NASDAQ:TSLA)
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow

Subscribe Now

Subscribe to our newsletter to get our newest articles instantly!

Most Popular
2 progress shares backed by this British fund that’s soared 77.8% in simply 3 years!
2 progress shares backed by this British fund that’s soared 77.8% in simply 3 years!
July 21, 2025
Overlook ‘Wealth’: Warren Buffett Says This Phrase Is the True Measure of Success
Overlook ‘Wealth’: Warren Buffett Says This Phrase Is the True Measure of Success
July 21, 2025
Centre to decontrol family antiseptic gross sales
Centre to decontrol family antiseptic gross sales
July 21, 2025
Axis Financial institution, Tech Mahindra & 4 different shares to purchase now for an upside of as much as 41%; Do you personal any?
Axis Financial institution, Tech Mahindra & 4 different shares to purchase now for an upside of as much as 41%; Do you personal any?
July 21, 2025
Inventory market at present: Reside updates
Inventory market at present: Reside updates
July 21, 2025

You Might Also Like

NHA to roll out India’s medical insurance scheme in Delhi after new govt’s approval
Business

NHA to roll out India’s medical insurance scheme in Delhi after new govt’s approval

5 Min Read
Sydney’s 2024 New Yr’s Eve fireworks set to dazzle the world – The place to look at
Business

Sydney’s 2024 New Yr’s Eve fireworks set to dazzle the world – The place to look at

8 Min Read
US is not operating commerce deficit with India, assume tank GTRI decodes hidden surplus
Business

US is not operating commerce deficit with India, assume tank GTRI decodes hidden surplus

6 Min Read
‘Lag raha hai gentle present me aaya hoon’: Netizens slam man for evaluating Coldplay Abu Dhabi live performance to Diljit Dosanjh’s
Business

‘Lag raha hai gentle present me aaya hoon’: Netizens slam man for evaluating Coldplay Abu Dhabi live performance to Diljit Dosanjh’s

3 Min Read

Always Stay Up to Date

Subscribe to our newsletter to get our newest articles instantly!

StockWaves

We provide tips, tricks, and advice for improving websites and doing better search.

Latest News

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms Of Service

Resouce

  • Blockchain
  • Business
  • Economics
  • Financial News
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading

Trending

2 progress shares backed by this British fund that’s soared 77.8% in simply 3 years!
Overlook ‘Wealth’: Warren Buffett Says This Phrase Is the True Measure of Success
Centre to decontrol family antiseptic gross sales

2024 © StockWaves.in. All Rights Reserved.

Welcome Back!

Sign in to your account

Not a member? Sign Up